Valuation: Gulf Pharmaceutical Industries

Market Cap 1.11B 301M 270M 250M 226M 422M 28.66B 428M 2.98B 1.19B 15B 1.13B 47.62B P/E 2026 *
-
P/E 2027 * 7.36x
Enterprise Value 936M 255M 229M 211M 191M 357M 24.26B 362M 2.53B 1.01B 12.69B 956M 40.29B EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.7x
Free-Float
34.75%
Yield 2026 *
-
Yield 2027 * -
1 day-1.34%
1 week-0.42%
Current month-7.09%
1 month-7.09%
3 months-8.86%
6 months-11.39%
Current year-18.21%
1 week 0.91
Extreme 0.91
0.98
1 month 0.91
Extreme 0.91
1.07
Current year 0.91
Extreme 0.91
1.26
1 year 0.91
Extreme 0.91
1.47
3 years 0.73
Extreme 0.73
1.78
5 years 0.7
Extreme 0.701
2.04
10 years 0.7
Extreme 0.701
4.51
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 01/01/2017
Director/Board Member - 01/01/2019
Chairman - 01/01/2005
Change 5-day change 1-year change 3-year change Capi.($)
-1.34%-0.42%-22.82%+27.43% 305M
+0.50%+0.36%+55.89%+129.96% 1,143B
+0.86%+4.50%+42.43%+86.15% 647B
-0.14%-1.07%+25.42%+105.85% 506B
-0.05%+2.28%+49.14%+67.74% 384B
-0.63%-4.97%+60.15%+37.06% 350B
+0.34%+2.15%+25.26%+54.27% 293B
-0.45%+1.16%+1.74%+26.08% 265B
+0.87%+2.94%+55.18%+72.74% 242B
+0.08%+1.72%+32.15%+107.78% 197B
Average +0.34%+0.86%+32.45%+71.51% 402.78B
Weighted average by Cap. +0.92%+0.71%+42.62%+89.01%

Financials

2026 *2027 *
Net sales 1.15B 314M 281M 260M 236M 440M 29.87B 445M 3.11B 1.24B 15.63B 1.18B 49.62B 1.24B 338M 303M 280M 254M 474M 32.18B 480M 3.35B 1.33B 16.84B 1.27B 53.45B
Net income 99M 26.95M 24.18M 22.36M 20.25M 37.83M 2.57B 38.28M 267M 106M 1.34B 101M 4.26B 148M 40.29M 36.15M 33.42M 30.27M 56.55M 3.84B 57.23M 400M 159M 2.01B 151M 6.37B
Net Debt -170M -46.28M -41.52M -38.39M -34.77M -64.95M -4.41B -65.74M -459M -183M -2.31B -174M -7.32B -232M -63.16M -56.66M -52.39M -47.45M -88.64M -6.02B -89.71M -626M -249M -3.15B -237M -9.99B
Projected Income Statement - Annual - Gulf Pharmaceutical Industries
Logo Gulf Pharmaceutical Industries
Gulf Pharmaceutical Industries Julphar Co PJSC is a United Arab Emirates based pharmaceutical company. The Company is engaged in manufacturing and selling of medicines, drugs and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The Company’s segments include Manufacturing, Planet, Investments. The products of the Company include general medicines, diabetes solutions, cardiovascular care, consumer healthcare products, wound care and dermatology, respiratory and git medicines. The Company’s subsidiaries include mena cool transportation f.z.e., julphar pharmaceuticals p.l.c., julphar ses l.l.c., diabtec l.l.c and others.
Employees
2,400
Date Price Change Volume
28/10/26 AED 0.9570 -1.34% 187,968
27/10/26 AED 0.9700 +2.11% 1,123,677
26/10/26 AED 0.9500 +3.26% 1,776,722
23/10/26 AED 0.9200 -1.92% 1,414,478
22/10/26 AED 0.9380 +0.32% 2,498,821
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Gulf Pharmaceutical Industries
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9570AED
Average target price
1.720AED
Spread / Average Target
+79.73%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Gulf Pharmaceutical Industries
  1. Stock Market
  2. Stocks
  3. JULPHAR Stock